Milad Alucozai

Co-Founder & General Partner

Computational neuroscientist and serial founder, named to Business Insider's Top 100. Has invested across 100+ early-stage technical companies representing more than $10Bn in value. Identifies true technology innovation vs. science projects and spots what incumbents miss.

• Business Insider 2025 — Top 100 Early-Stage Investor
• Neuroscientist & Co-founder, Revalia Bio
• Current External Advisor to Amgen & Board Member at Critical Path Institute
• Led 70 early-stage investments at BoxOne Ventures and Former Venture Partner at Entrepreneur First
• Invested in over 100 startups with >$10b in enterprise value
• Former EIR supporting ARPA-H contracts ($1.5b)
• Former operator and advisor at Accenture, Absci, bit.bio, Numerate, Mekonos, and AstraZeneca
• Former Visiting Scholar at the Wyss Institute, Harvard Medical School